Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker SAIC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | C. David Cush Director | SAIC Science Applications International Corporation | Buy | 1,000 | $132.50 | $132.5K Buy | Form 4 ↗ |
| Apr 9, 2026 | Srinivas Attili EVP, Civilian | SAIC Science Applications International Corporation | Buy | 100 | $94.96 | $9,496 Buy | Form 4 ↗ |
| Dec 31, 2025 | Srinivas Attili EVP, Civilian | SAIC Science Applications International Corporation | Buy | 100 | $101.26 | $10.1K Buy | Form 4 ↗ |
| Dec 23, 2025 | Vincent P. DiFronzo EVP,-Air Force & Comb Commands | SAIC Science Applications International Corporation | Buy | 150 | $102.89 | $15.4K Buy | Form 4 ↗ |
| Dec 16, 2025 | Hilary Hageman EVP General Counsel, Secretary | SAIC Science Applications International Corporation | Buy | 100 | $100.21 | $10.0K Buy | Form 4 ↗ |
| Dec 16, 2025 | James Reagan Interim CEO, Director | SAIC Science Applications International Corporation | Buy | 1,000 | $100.17 | $100.2K Buy | Form 4 ↗ |
| Dec 16, 2025 | Prabu Natarajan EVP, Chief Financial Officer | SAIC Science Applications International Corporation | Buy | 2,000 | $100.49 | $201.0K Buy | Form 4 ↗ |
| Oct 10, 2025 | Srinivas Attili EVP, Civilian | SAIC Science Applications International Corporation | Buy | 100 | $97.35 | $9,735 Buy | Form 4 ↗ |
| Jun 3, 2025 | Srinivas Attili EVP, Civilian | SAIC Science Applications International Corporation | Buy | 100 | $102.03 | $10.2K Buy | Form 4 ↗ |
| Apr 14, 2025 | Garth Graham Director | SAIC Science Applications International Corporation | Buy | 215 | $116.75 | $25.1K Buy | Form 4 ↗ |
| Apr 7, 2025 | Carolyn B. Handlon Director | SAIC Science Applications International Corporation | Buy | 230 | $109.93 | $25.3K Buy | Form 4 ↗ |
| Apr 4, 2025 | Srinivas Attili EVP, Civilian | SAIC Science Applications International Corporation | Buy | 100 | $111.75 | $11.2K Buy | Form 4 ↗ |
| Apr 2, 2025 | John K. Tien Jr. Director | SAIC Science Applications International Corporation | Buy | 215 | $116.50 | $25.0K Buy | Form 4 ↗ |
| Mar 28, 2025 | Toni Townes-Whitley Chief Executive Officer, Director | SAIC Science Applications International Corporation | Buy | 1,404 | $111.74 | $156.9K Buy | Form 4 ↗ |
| Mar 28, 2025 | Toni Townes-Whitley Chief Executive Officer, Director | SAIC Science Applications International Corporation | Buy | 596 | $111.50 | $66.5K Buy | Form 4 ↗ |
| Mar 28, 2025 | James Reagan Director | SAIC Science Applications International Corporation | Buy | 450 | $112.10 | $50.4K Buy | Form 4 ↗ |
| Mar 27, 2025 | Katharina G. McFarland Director | SAIC Science Applications International Corporation | Buy | 230 | $109.86 | $25.3K Buy | Form 4 ↗ |
| Mar 27, 2025 | Milford W. McGuirt Director | SAIC Science Applications International Corporation | Buy | 500 | $110.58 | $55.3K Buy | Form 4 ↗ |
| Mar 26, 2025 | Barbara Supplee EVP, Navy | SAIC Science Applications International Corporation | Buy | 360 | $109.61 | $39.5K Buy | Form 4 ↗ |
| Mar 26, 2025 | Prabu Natarajan EVP, Chief Financial Officer | SAIC Science Applications International Corporation | Buy | 2,000 | $109.55 | $219.1K Buy | Form 4 ↗ |
| Mar 26, 2025 | Hilary Hageman EVP General Counsel, Secretary | SAIC Science Applications International Corporation | Buy | 100 | $109.74 | $11.0K Buy | Form 4 ↗ |
| Mar 25, 2025 | Vincent P. DiFronzo EVP,-Air Force & Comb Commands | SAIC Science Applications International Corporation | Buy | 597 | $108.85 | $65.0K Buy | Form 4 ↗ |
| Jan 13, 2025 | Katharina G. McFarland Director | SAIC Science Applications International Corporation | Sale | 3,239 | $117.70 | $381.2K Sale | Form 4 ↗ |
| Dec 17, 2024 | Srinivas Attili EVP, Civilian | SAIC Science Applications International Corporation | Buy | 100 | $113.42 | $11.3K Buy | Form 4 ↗ |
| Dec 16, 2024 | Vincent P. DiFronzo EVP,-Air Force & Comb Commands | SAIC Science Applications International Corporation | Buy | 150 | $112.59 | $16.9K Buy | Form 4 ↗ |
| Dec 11, 2024 | Barbara Supplee EVP, Navy | SAIC Science Applications International Corporation | Buy | 425 | $116.36 | $49.5K Buy | Form 4 ↗ |
26 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances